Dark
Light
Today: April 20, 2025
August 1, 2024
1 min read

venBio Secures $528M for Life Sciences Investment



TLDR:

  • VenBio raises $528 million for fifth life sciences VC fund
  • Fund V investors include sovereign wealth funds, corporate pensions, and more

VenBio, a veteran venture capital firm, has raised $528 million for its fifth life sciences investment fund. The fundraising began mid-April and attracted diverse investors from various sectors. The firm, based in San Francisco, focuses on investing in biotechs working on diseases with unmet needs and is interested in all stages of clinical development. VenBio has a successful track record of investing in companies that have been acquired or gone public, such as Aragon Pharmaceuticals and Seragon Pharmaceuticals. Fund V aims to maintain consistency in strategy, team, and investment discipline.


Previous Story

Support our mission: Funding Israeli military drones for defense

Next Story

Knowde secures Sequoia funding in Series C with valuation decrease

Latest from Blog

VCFA Group Closes $1225M Venture Partners VII Fund

TLDR: VCFA Group closed VCFA Venture Partners VII fund with $122.5 million in commitments Transition marks continuation of VCFA’s pioneering legacy in the secondary private equity space VCFA Group, a pioneer in

Top AI Trends and Startups Shaping 2025 and Beyond

“`html TLDR: Israel is excelling in applicative and vertical AI, focusing on practical solutions in cybersecurity, healthcare, and defense rather than competing with tech giants in foundational AI models. Five key AI
Go toTop